Home - Annals of Pancreatic Cancer

APC Annual Report 2021

Greetings from Editor-in-Chief and Editorial Office of Annals of Pancreatic Cancer!

We are pleased to share the 2021 Annual Report of Annals of Pancreatic Cancer here.

We would especially like to express our sincere gratitude to all supporters especially the editorial team members for all your support and contributions to Annals of Pancreatic Cancer from the inception of the journal. In 2022, we welcome more excellent international experts of the field to join and contribute to build APC a significant platform serving our scientists, doctors, patients and students in the field of pancreas. Wish you a happy, healthy and prosperous 2022!

Annals of Pancreatic Cancer (APC) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Annals of Pancreatic Cancer (APC) is among the list of COPE membership.

Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions

This manuscript describes the options in human models of pancreatic ductal adenocarcinoma and discusses how these models can be applied to translational research with an eye towards the clinical care of patients stricken with this disease.

MRI screening in hereditary pancreatic cancer: value of various sequences in the detection of early pancreatic cancer

The inversion recovery prepulse of T1-TFE increases contrast between normal and abnormal pancreatic tissue. Knowledge of imaging features and recognition of subtle changes in the pancreas could improve detection of early pancreatic cancer in a high-risk screening population.

Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging

T1C significantly increases in all phases of CE-MRI in responders to treatment, but does not change in non-responders. T1C correlates with treatment response, can be computed from clinical MRI exams, and may be useful as an additional metric to stratify patients undergoing treatment.

AME entered an official partnership with Publons to enhance wide-ranging recognition for reviewers

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020. Around 60 AME journals’ peer review systems are now integrated seamlessly into the Publons platform (https://publons.com/about/home). The partnership was done to recognize our expert peer reviewers spontaneously for their review contribution.

Why do we need a journal solely focused on the malignant diseases of the pancreas?

Pancreatic cancer has become the third leading cause of death from malignant diseases in both the United States and Europe. The incidence of pancreatic cancer is rising. Tremendous efforts have been devoted to basic and clinical research in pancreatic cancer. However, the outcome of pancreatic cancer has been minimally improved over the last thirty years. Such a profound sadness tells us that we should spend more efforts and be more focused on this disease. There had been no scientific journal that is solely focused on the malignant diseases of the pancreas. It is critical to have a media to rapidly disseminate research news and reports within the communities of pancreatic cancer researchers and have a venue to discuss the management strategies for pancreatic cancer among clinicians. This is why we are launching Annals of Pancreatic Cancer.

‹ ›

About apc

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: apc@amegroups.com
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Original Article

EBF2 contributes to pancreatic cancer progenitor cell differentiation and tumor suppression

Hannah Mathew, Jennifer J. Barb, Soren Bentzen, Sheelu Varghese

Annals of Pancreatic Cancer

2022;

(10 April 2022)

PDF Full Text Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article 

Drain and nasogastric tube use following pancreatoduodenectomy: a narrative review

Thomas B. Russell, Peter L. Labib, Somaiah Aroori

Annals of Pancreatic Cancer

2022;

(31 March 2022)

PDF Full Text Reporting Checklist Peer Review File COI Form Open Access

Review Article 

Selected intra-operative factors which affect pancreaticoduodenectomy outcomes: a narrative review

Thomas B. Russell, Peter L. Labib, Somaiah Aroori

Annals of Pancreatic Cancer

2022;

(31 March 2022)

PDF Full Text Reporting Checklist Peer Review File COI Form Open Access

Original Article

Blood transfusion is associated with worse outcomes following pancreatic resection for pancreatic adenocarcinoma

Ammar A. Javed, Sean M. Ronnekleiv-Kelly, Alina Hasanain, Michael J. Pflüger, Joseph R. Habib, Michael J. Wright, Jin He, John L. Cameron, Christopher L. Wolfgang, Steven M. Frank, Matthew J. Weiss, Richard A. Burkhart

Annals of Pancreatic Cancer

2022;

(31 March 2022)

PDF Full Text Reporting Checklist Data Sharing Statement COI Form Open Access

Review Article 

Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: a systematic review

Thomas B. Russell, Peter L. Labib, Somaiah Aroori

Annals of Pancreatic Cancer

2021;

(10 November 2021)

PDF Full Text Reporting Checklist Peer Review File COI Form Open Access

Case Report

Case series: FDG-avid lymphadenopathy during oncologic staging of pancreatic adenocarcinoma after COVID-19 vaccination

John M. Nathan, Patrick J. Navin, Mark J. Truty, Benzon M. Dy

Annals of Pancreatic Cancer

2021;

(30 October 2021)

PDF Full Text Reporting Checklist COI Form Open Access

Review Article 

The robotic central pancreatectomy: surgical technique, and literature review

Krishna Kotecha, Advait Pandya, Ramesh Damodaran Prabha, Rudra Maitra, Anubhav Mittal, Jaswinder S. Samra

Annals of Pancreatic Cancer

2021;

(30 October 2021)

PDF Full Text Peer Review File COI Form Open Access

Original Article

A single-institutional analysis of racial disparities in clinicopathologic characteristics, treatment selections, and outcomes in advanced-stage pancreatic cancer patients

Matthew Williams, Umut Özbek, Jung-Yi Lin, Celina Ang

Annals of Pancreatic Cancer

2021;

(30 October 2021)

PDF Full Text Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Original Article

Pancreatic adenocarcinoma in liver transplant recipients: a case series

Muhammad A. Rauf, Ioannis A. Ziogas, Julia M. Sealock, Lea K. Davis, Manhal Izzy, Sophoclis P. Alexopoulos, Lea K. Matsuoka

Annals of Pancreatic Cancer

2021;

(30 October 2021)

PDF Full Text Reporting Checklist COI Form Open Access

Review Article 

Solid pseudopapillary neoplasm of the pancreas: cytomorphology, pitfalls, and literature review

Payam S. Pahlavan, Amer Khiyami, Santhi Ganesan

Annals of Pancreatic Cancer

2021;

(30 July 2021)

PDF Full Text COI Form Open Access

Review Article 

Volatile organic compound analysis for the diagnosis of pancreatic cancer

Benjamin T. Crosby, Adam Ridzuan-Allen, John P. O’Neill

Annals of Pancreatic Cancer

2021;

(30 July 2021)

PDF Full Text COI Form Open Access

Original Article

A national database analysis of acinar cell carcinoma of the pancreas, a histologically, epidemiologically, and biologically distinct entity increasing in incidence

Jennifer A. Yonkus, John R. Bergquist, Roberto Alva-Ruiz, Tommy Ivanics, Elizabeth B. Habermann, Amro M. Abdelrahman, Travis E. Grotz, Sean P. Cleary, Rory L. Smoot, David M. Nagorney, Michael L. Kendrick, Thorvardur R. Halfdanarson, Mark J. Truty

Annals of Pancreatic Cancer

2021;

(30 July 2021)

PDF Full Text COI Form Open Access

Original Article

A Phase 1b clinical trial of LDE225 (Sonidegib) in combination with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in previously untreated locally advanced or metastatic pancreatic adenocarcinoma

Jeffrey W. Clark, Nora Horick, Jill N. Allen, Lawrence S. Blaszkowsky, Janet E. Murphy, Charles S. Fuchs, Brian M. Wolpin, Robert J. Mayer, Jason E. Farris, Jennifer A. Chan, Kimmie Ng, Nadine J. McCleary, Thomas A. Abrams, David P. Ryan, Eunice L. Kwak, Theodore S. Hong

Annals of Pancreatic Cancer

2021;

(30 July 2021)

PDF Full Text Data Sharing Statement COI Form Open Access

Original Article

Association of germline ATM mutations and survival in pancreatic cancer

Arjan Gower, Gillian Gresham, Kellie Spector, Nanor Haladjian, John Lee, Sejal Mehta, Arsen Osipov, Andrew Hendifar

Annals of Pancreatic Cancer

2021;

(30 July 2021)

PDF Full Text Data Sharing Statement COI Form Open Access

Review Article 

Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions

Reecha Suri, Jacquelyn W. Zimmerman, Richard A. Burkhart

Annals of Pancreatic Cancer

2020;

(29 December 2020)

PDF Full Text COI Form Open Access

Original Article

MRI screening in hereditary pancreatic cancer: value of various sequences in the detection of early pancreatic cancer

Bas Boekestijn, Shirin Feshtali, Arnoud C. Meijer, Isaura S. Ibrahim, Arantza Farina-Sarasqueta, Akin Inderson, Bert A. Bonsing, Andrew G. Webb, Hans F. Vasen, Martin N. Wasser

Annals of Pancreatic Cancer

2020;

(30 November 2020)

PDF Full Text Data Sharing Statement COI Form Open Access

Original Article

Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging

Joy Liau, Srinivasan Vedantham, Hani M. Babiker, Travis McGlothin, Diego R. Martin

Annals of Pancreatic Cancer

2020;

(25 November 2020)

PDF Full Text Data Sharing Statement COI Form Open Access

Case Report

Primary squamous cell carcinoma of the pancreas: case report and literature review

Arig Abas Mussa, Ciaran F. Healy, Julie McCarthy

Annals of Pancreatic Cancer

2020;

(23 November 2020)

PDF Full Text COI Form Open Access

Original Article

Fluoropyrimidine-based maintenance chemotherapy after FOLFIRINOX for patients with metastatic pancreatic adenocarcinoma: a retrospective analysis

Marina Junqueira de Almeida, Celso Abdon Lopes de Mello, Marcos Pedro Guedes Camandaroba, Victor Hugo Fonseca de Jesus

Annals of Pancreatic Cancer

2020;

(10 November 2020)

PDF Full Text Reporting Checklist Data Sharing Statement COI Form Open Access

Original Article

Predictive factors of improved postoperative outcomes in pancreatic resection include patient insurance status and facility surgical volume

Daniel Sykora, Natalie Landman, Richard J. Butterfield III, Tanios S. Bekaii-Saab, Yu-Hui Chang, Denis A. Cortese

Annals of Pancreatic Cancer

2020;

(15 October 2020)

PDF Full Text COI Form Open Access

View more articles

Currently no content available!

Original Article

Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging

Joy Liau, Srinivasan Vedantham, Hani M. Babiker, Travis McGlothin, Diego R. Martin

Nonselective β-adrenergic blockade impacts pancreatic cancer tumor biology, decreases perineural invasion and improves patient survival

Alex B. Blair, Noelle R. Jurcak, Ammar Javed, Jonathan Teinor, Vincent P. Groot, Noah Rozich, John L. Cameron, Matthew J. Weiss, Jin He, Christopher L. Wolfgang, Lei Zheng, Richard A. Burkhart

Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution

Alejandro Recio-Boiles, Jessica Vondrak, Summana Veeravelli, James J. Mancuso, Kathylynn Saboda, Denise J. Roe, Irbaz Bin Riaz, Aaron J. Scott, Emad Elquza, Ali McBride, Hani M. Babiker

Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma

May Tun Saung, Lei Zheng

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios inversely correlate to clinical and pathologic stage in patients with resectable pancreatic ductal adenocarcinoma

Alejandro Recio-Boiles, Aparna Nallagangula, Summana Veeravelli, Jessica Vondrak, Kathylynn Saboda, Denise Roe, Emad Elquza, Ali McBride, Hani M. Babiker

Review Article 

Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions

Reecha Suri, Jacquelyn W. Zimmerman, Richard A. Burkhart

Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma

Mengni He, MacKenzie Henderson, Stephen Muth, Adrian Murphy, Lei Zheng

Targeting homologous recombination addicted tumors: challenges and opportunities

Talia Golan, Jonathan R. Brody

Evolving trends in pancreatic cancer therapeutic development

Imani Bijou, Jin Wang

Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors

Jessica L. Buicko, Brendan M. Finnerty, Tiantian Zhang, Bu Jung Kim, Thomas J. Fahey III, Yi-Chieh Nancy Du

Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma

Yi Xu, Jun Liu, Michael Nipper, Pei Wang

Malnutrition, frailty, and sarcopenia in pancreatic cancer patients: assessments and interventions for the pancreatic surgeon

Noah S. Rozich, Caitlin E. Jones, Katherine T. Morris

Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence

Adam R. Wolfe, Terence M. Williams

Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy

Sweet Ping Ng, Eugene J. Koay

Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma

Nikhil Yegya-Raman, Mihir M. Shah, Miral S. Grandhi, Elizabeth Poplin, David A. August, Timothy J. Kennedy, Usha Malhotra, Kristen R. Spencer, Darren R. Carpizo, Salma K. Jabbour

Robotic distal pancreatectomy: greatest benefit for the frail?

Ioannis T. Konstantinidis, Laleh G. Melstrom

Editorial

Stressing for sugar: a new role of serotonin for glycolysis in pancreatic cancer cells

Gregory B. Lesinski

Can computational modeling help in personalizing the care of patients with pancreatic ductal adenocarcinoma?

Efrat Dotan

Perspective 

Immune defects in pancreatic cancer

Lei Zheng

Journal Highlight more

Annals of Pancreatic Cancer is an international, open access, peer-reviewed journal for all researchers in the field of pancreatic cancer and for all health care providers who manage the care of pancreatic cancer patients, covering areas of basic biology and immunology, epidemiology, prevention, diagnosis, treatment, and supportive care.

Indexing

In Scopus

Membership

Publishing Information

Annals of Pancreatic Cancer is published by AME Publishing Company

Why do we need a journal solely focused on the malignant diseases of the pancreas?

About apc

Manuscript Submission

AME Editing Service

Reprint & Permission

Contact us

General editorial enquiries:

Copyright related contact:

Commercial Sales contact (Reprints, advertising, etc.):

Original Article

Review Article

Editorial

Perspective

Indexing

Membership

Publishing Information

Review Article 

Perspective 